Treatment of Acinetobacter Infections

被引：264

作者：

Fishbain, Joel ^{[1
]}

Peleg, Anton Y. ^{[2
,3
,4
,5
]}

机构：

[1] St John Hosp & Med Ctr, Div Infect Dis, Detroit, MI USA

[2] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA

[3] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA

[4] Alfred Hosp, Melbourne, Vic, Australia

[5] Monash Univ, Dept Microbiol, Melbourne, Vic 3004, Australia

来源：

CLINICAL INFECTIOUS DISEASES | 2010年 / 51卷 / 01期

关键词：

CRITICALLY-ILL PATIENTS; BLOOD-STREAM INFECTION; PSEUDOMONAS-AERUGINOSA; ATTRIBUTABLE MORTALITY; CALCOACETICUS COMPLEX; AMPICILLIN-SULBACTAM; BAUMANNII BACTEREMIA; COMBINATION THERAPY; IMIPENEM-CILASTATIN; MEROPENEM;

D O I：

10.1086/653120

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Acinetobacter baumannii remains an important and difficult-to-treat pathogen whose resistance patterns result in significant challenges for the clinician. Despite the prevalence and interest in A. baumannii infections, there is relatively limited well-controlled scientific data to help the clinician select optimal empirical and subsequent targeted therapy for a variety of infections. We will review the currently available antimicrobial agents and discuss the clinical data supporting the use of the various agents.

引用

页码：79 / 84

页数：6

共 43 条

[1] Aminoglycoside Resistance and Susceptibility Testing Errors in Acinetobacter baumannii-calcoaceticus Complex [J].

Akers, Kevin S. ;

Chaney, Chris ;

Barsoumian, Alice ;

Beckius, Miriam ;

Zera, Wendy ;

Yu, Xin ;

Guymon, Charles ;

Keen, Edward F., III ;

Robinson, Brian J. ;

Mende, Katrin ;

Murray, Clinton K. .

JOURNAL OF CLINICAL MICROBIOLOGY, 2010, 48 (04) :1132-1138

[2] Tetracycline Susceptibility Testing and Resistance Genes in Isolates of Acinetobacter baumannii-Acinetobacter calcoaceticus Complex from a US Military Hospital [J].

Akers, Kevin S. ;

Mende, Katrin ;

Yun, Heather C. ;

Hospenthal, Duane R. ;

Beckius, Miriam L. ;

Yu, Xin ;

Murray, Clinton K. .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (06) :2693-2695

[3] Colistin and rifampicin in the treatment of multidrug-resistant Acinetobacter baumannii infections [J].

Bassetti, M. ;

Repetto, E. ;

Righi, E. ;

Boni, S. ;

Diverio, M. ;

Molinari, M. P. ;

Mussap, M. ;

Artioli, S. ;

Ansaldi, F. ;

Durando, P. ;

Orengo, G. ;

Pallavicini, F. Bobbio ;

Viscoli, C. .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 61 (02) :417-420

[4] Minocycline-an old drug for a new century: emphasis on methicillin-resistant Staphylococcus aureus (MRSA) and Acinetobacter baumannii [J].

Bishburg, Eliahu ;

Bishburg, Kathryn .

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2009, 34 (05) :395-401

[5]

CASCIO A, 2009, INT J INFECT DIS

[6] Effectiveness and nephrotoxicity of colistin monotherapy vs. colistin-meropenem combination therapy for multidrug-resistant Gram-negative bacterial infections [J].

Falagas, M. E. ;

Rafailidis, P. L. ;

Kasiakou, S. K. ;

Hatzopoulou, P. ;

Michalopoulos, A. .

CLINICAL MICROBIOLOGY AND INFECTION, 2006, 12 (12) :1227-1230

[7] Attributable mortality of Acinetobacter baumannii:: no longer a controversial issue [J].

Falagas, Matthew E. ;

Rafailidis, Petros I. .

CRITICAL CARE, 2007, 11 (03)

[8] Attributable mortality of Acinetobacter baumannii infections in critically ill patients:: a systematic review of matched cohort and case-control studies [J].

Falagas, Matthew E. ;

Bliziotis, Ioannis A. ;

Siempos, Ilias I. .

CRITICAL CARE, 2006, 10 (02)

[9] Colistin: The revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections [J].

Falagas, ME ;

Kasiakou, SK .

CLINICAL INFECTIOUS DISEASES, 2005, 40 (09) :1333-1341

[10] In vitro activities of three carbapenems against recent bacterial isolates from severely ill patients at Swedish hospitals [J].

Fraenkel, Carl-Johan ;

Ullberg, Mans ;

Bernander, Sverker ;

Ericson, Evalena ;

Larsson, Peter ;

Rydberg, Johan ;

Tornqvist, Eva ;

Melhus, Asa .

SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2006, 38 (10) :853-859

← 1 2 3 4 5 →